Creo Medical

Richard Thompson
Senior Investment Executive

"We’re delighted by the support we’ve received over multiple funding rounds."

Craig Gulliford, CEO

Creo Medical is an emerging Med-Tech leader. They're developing innovative and groundbreaking medical technologies that will provide substantial benefits to the medical community, vastly improving the outcomes of a range of medical procedures.

Creo are developing a range of surgical devices that can dissect tissue while using special microwaves to staunch the blood flow.

They’re our fourth portfolio company to list on AIM in the last four years. The company successfully raised over £20 million with their initial public offering (IPO) in December 2016.   

 

Company information

Location
Chepstow